vs
弗雷斯特研究公司（FORR）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
弗雷斯特研究公司的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.8倍（$101.1M vs $57.3M），弗雷斯特研究公司净利率更高（-33.5% vs -83.0%，领先49.5%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs -6.5%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs 0.5%）
福雷斯特研究公司是一家全球领先的研究咨询机构，主营业务涵盖行业研究、管理咨询与行业峰会举办，客户群体包括全球大型企业、科技公司与消费领域领军企业，公司总部位于美国马萨诸塞州剑桥市。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
FORR vs RYTM — 直观对比
营收规模更大
FORR
是对方的1.8倍
$57.3M
营收增速更快
RYTM
高出43.3%
-6.5%
净利率更高
FORR
高出49.5%
-83.0%
两年增速更快
RYTM
近两年复合增速
0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $101.1M | $57.3M |
| 净利润 | $-33.9M | $-47.5M |
| 毛利率 | 56.7% | 91.6% |
| 营业利润率 | -36.6% | -82.2% |
| 净利率 | -33.5% | -83.0% |
| 营收同比 | -6.5% | 36.9% |
| 净利润同比 | -7941.4% | -9.6% |
| 每股收益（稀释后） | $-1.75 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORRRYTM
| Q4 25 | $101.1M | $57.3M | ||
| Q3 25 | $94.3M | $51.3M | ||
| Q2 25 | $111.7M | $48.5M | ||
| Q1 25 | $89.9M | $32.7M | ||
| Q4 24 | $108.0M | $41.8M | ||
| Q3 24 | $102.5M | $33.3M | ||
| Q2 24 | $121.8M | $29.1M | ||
| Q1 24 | $100.1M | $26.0M |
净利润FORRRYTM
| Q4 25 | $-33.9M | $-47.5M | ||
| Q3 25 | $-2.1M | $-52.9M | ||
| Q2 25 | $3.9M | $-46.6M | ||
| Q1 25 | $-87.3M | $-49.5M | ||
| Q4 24 | $432.0K | $-43.3M | ||
| Q3 24 | $-5.8M | $-43.6M | ||
| Q2 24 | $6.3M | $-32.3M | ||
| Q1 24 | $-6.7M | $-141.4M |
毛利率FORRRYTM
| Q4 25 | 56.7% | 91.6% | ||
| Q3 25 | 60.0% | 89.3% | ||
| Q2 25 | 55.5% | 88.6% | ||
| Q1 25 | 55.9% | 88.8% | ||
| Q4 24 | 58.8% | 90.9% | ||
| Q3 24 | 60.5% | 88.5% | ||
| Q2 24 | 57.3% | 89.9% | ||
| Q1 24 | 54.9% | 89.2% |
营业利润率FORRRYTM
| Q4 25 | -36.6% | -82.2% | ||
| Q3 25 | 4.7% | -102.6% | ||
| Q2 25 | 6.2% | -93.4% | ||
| Q1 25 | -97.5% | -143.7% | ||
| Q4 24 | -0.5% | -98.6% | ||
| Q3 24 | -0.7% | -132.0% | ||
| Q2 24 | 9.3% | -139.2% | ||
| Q1 24 | -9.3% | -538.7% |
净利率FORRRYTM
| Q4 25 | -33.5% | -83.0% | ||
| Q3 25 | -2.3% | -103.1% | ||
| Q2 25 | 3.5% | -96.1% | ||
| Q1 25 | -97.1% | -151.4% | ||
| Q4 24 | 0.4% | -103.6% | ||
| Q3 24 | -5.7% | -131.2% | ||
| Q2 24 | 5.2% | -110.9% | ||
| Q1 24 | -6.7% | -544.4% |
每股收益（稀释后）FORRRYTM
| Q4 25 | $-1.75 | $-0.73 | ||
| Q3 25 | $-0.11 | $-0.82 | ||
| Q2 25 | $0.20 | $-0.75 | ||
| Q1 25 | $-4.62 | $-0.81 | ||
| Q4 24 | $0.02 | $-0.71 | ||
| Q3 24 | $-0.30 | $-0.73 | ||
| Q2 24 | $0.33 | $-0.55 | ||
| Q1 24 | $-0.35 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.3M | $388.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $126.5M | $139.1M |
| 总资产 | $404.0M | $480.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FORRRYTM
| Q4 25 | $63.3M | $388.9M | ||
| Q3 25 | $65.1M | $416.1M | ||
| Q2 25 | $67.8M | $291.0M | ||
| Q1 25 | $75.6M | $314.5M | ||
| Q4 24 | $56.1M | $320.6M | ||
| Q3 24 | $62.8M | $298.4M | ||
| Q2 24 | $58.9M | $319.1M | ||
| Q1 24 | $61.4M | $201.2M |
股东权益FORRRYTM
| Q4 25 | $126.5M | $139.1M | ||
| Q3 25 | $157.7M | $148.8M | ||
| Q2 25 | $159.5M | $-11.9M | ||
| Q1 25 | $147.4M | $18.9M | ||
| Q4 24 | $229.5M | $21.7M | ||
| Q3 24 | $234.3M | $11.2M | ||
| Q2 24 | $237.1M | $39.3M | ||
| Q1 24 | $230.9M | $61.6M |
总资产FORRRYTM
| Q4 25 | $404.0M | $480.2M | ||
| Q3 25 | $414.2M | $506.9M | ||
| Q2 25 | $436.0M | $372.7M | ||
| Q1 25 | $439.8M | $386.7M | ||
| Q4 24 | $503.9M | $392.3M | ||
| Q3 24 | $505.3M | $363.6M | ||
| Q2 24 | $524.2M | $381.8M | ||
| Q1 24 | $555.7M | $258.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.2M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | $-4.3M | — |
| 自由现金流率自由现金流/营收 | -4.2% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $18.1M | — |
8季度趋势，按日历期对齐
经营现金流FORRRYTM
| Q4 25 | $-3.2M | $-25.4M | ||
| Q3 25 | $1.2M | $-26.6M | ||
| Q2 25 | $-3.6M | $-23.3M | ||
| Q1 25 | $26.7M | $-40.4M | ||
| Q4 24 | $-1.8M | $-18.8M | ||
| Q3 24 | $264.0K | $-25.2M | ||
| Q2 24 | $-2.9M | $-29.1M | ||
| Q1 24 | $611.0K | $-40.7M |
自由现金流FORRRYTM
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $524.0K | — | ||
| Q2 25 | $-4.2M | — | ||
| Q1 25 | $26.1M | — | ||
| Q4 24 | $-2.5M | — | ||
| Q3 24 | $-223.0K | — | ||
| Q2 24 | $-3.7M | — | ||
| Q1 24 | $-815.0K | — |
自由现金流率FORRRYTM
| Q4 25 | -4.2% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -3.8% | — | ||
| Q1 25 | 29.0% | — | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | -0.2% | — | ||
| Q2 24 | -3.1% | — | ||
| Q1 24 | -0.8% | — |
资本支出强度FORRRYTM
| Q4 25 | 1.1% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 1.4% | — |
现金转化率FORRRYTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.93× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -4.24× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.46× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FORR
| Research Segment | $82.2M | 81% |
| Consulting Segment | $16.2M | 16% |
| Billable Expenses | $1.5M | 2% |
| Professional Services | $1.4M | 1% |
RYTM
暂无分部数据
